Answers are grounded in this paper and cite their sources.
Adipose tissue inflammation continues to represent a significant area of research in immunometabolism. We have identified a transcription factor, EBF1, which crucially regulates the expression of numerous inflammatory loci in adipocytes. However, EBF1 appears to do so without physically binding to these inflammatory genes. Our research is currently focused on understanding this discrepancy, and we believe that future findings could pave the road for drug development aimed to block adipose inflammation at its source.
No takes yet. Share an insight, caveat, or question.
Michael J. Griffin (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: